Erasca, Inc. (ERAS)
11.60
+0.48
(+4.36%)
USD |
NASDAQ |
May 21, 16:00
11.61
0.00 (0.00%)
After-Hours: 19:59
Erasca Research and Development Expense (TTM) : 94.15M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Revolution Medicines, Inc. | 1.117B |
| Tango Therapeutics, Inc. | 127.14M |
| Scholar Rock Holding Corp. | 209.98M |
| Kymera Therapeutics, Inc. | 326.19M |
| Relay Therapeutics, Inc. | 258.14M |